PROTEIN KINASE B
Govt's public procurement directive to states may restrict competition: MTaI
The timing of the directive, issued this month, is surprising as the industry is actively discussing the means to streamline public procurement of medical devices without disturbing the demand-supply equation.
Torrent Pharma Q2 net profit up 36% at Rs 244 crore
The company's revenue from India business stood at Rs 899 crore for the September quarter...
GSK Pharma Q2 profit at Rs 503 crore
Revenue from operations stood at Rs 882.02 crore for the quarter under review as against Rs 816.31 crore...
UK regulator reinstates full GMP status of Indoco Remedies Goa facility
With this development, the company's operations in Europe will now take off on a fast-track, Indoco Remedies MD Aditi Panandikar said.
Alkem Laboratories Q1 net profit jumps 36% to Rs 187.29 crore
Company's India sales grew by 12.1% YOY, recording sales of Rs 1,222 cr.
Abbott India Q1 profit up 42% to Rs 117 crore
Total income for the quarter under review rose to Rs 1,028.49 crore as against Rs 866.68 crore for the same period a year ago.
Lupin Q1 net profit up 49 pc to Rs 303.05 crore
Consolidated sales for the quarter under review also rose to Rs 4,355.83 crore as against Rs 3,774.57 crore during the same period a year ago.
USFDA completes inspection of Strides Pharma Bengaluru plant
The company's facility in Bengaluru underwent a United States Food and Drug Administration (USFDA) inspection that ended on May 24, 2019, Strides Pharma Science said in a statement.
Fortis Healthcare posts Q4 net profit of Rs 151 crore
Consolidated revenue from operations increased to Rs 1,184.15 crore from Rs 1,086.38 crore in the same quarter a year ago.
Ebix commences due diligence to acquire Yatra
US-based software firm Ebix Inc Tuesday said it has commenced due diligence for signing an agreement to acquire Yatra Online Inc, the parent company of online travel firm Yatra.com, by May 15.
Biocon gets 6 observations from USFDA after inspection of its Bengaluru plant
Biocon is confident of addressing these expeditiously and remains committed to global standards of quality and compliance, the statement added.
Jubilant Life Sciences Q3 net profit up 26% to Rs 267.52 crore
The company had posted a net profit of Rs 212.84 crore for the corresponding period of the previous fiscal, Jubilant Life Sciences said in a filing to BSE.
Strides to exit investment in Arrow for AUD 394 million
In a separate filing, the company said its step-down subsidiary Strides Pharma Inc has entered into an arrangement to acquire 100 per cent stake in US-based generics company Vensun Pharmaceuticals Inc.
Hetero launches generic breast cancer treatment drug in India
Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country.
GSK Pharma Q2 profit down 23% to Rs 101 crore
Total income of the company stood at Rs 831.13 crore for the reported quarter.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service